Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous Cell Lung Cancer × iniparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 4 Neoplasms 4 Breast Neoplasms 4 Recurrence 2 Ovarian Neoplasms 2 Hypersensitivity 2 Squamous Cell Lung Cancer 1 Solid Tumors 1 Neoplasm Metastasis 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Female 1 Brain Neoplasms 1 Advanced Solid Tumors 1 Advance Solid Tumors 1

Interventions

Gemcitabine 2 Docetaxel 2 Carboplatin 2 iniparib 1 bleomycin A6 1 apatorsen 1 Pemetrexed 1 Injections 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01082549 2016-03-17

ECLIPSE

Sanofi

Phase 3 Completed

Squamous Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡